| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/07/2010 | US20100004303 Treatment of endocrine dysfunction using iron chelators |
| 01/07/2010 | US20100004295 Hydrazine amide derivative |
| 01/07/2010 | US20100004280 Substituted imidazoles as bombesin receptor subtype-3 modulators |
| 01/07/2010 | US20100004277 Compounds and methods for modulating protein trafficking |
| 01/07/2010 | US20100004273 Compounds And Methods For Treating Disorders Related To Glucose Metabolism |
| 01/07/2010 | US20100004272 Modulators of metabolism and the treatment of disorders related thereto |
| 01/07/2010 | US20100004263 Mtp inhibiting aryl piperidines or peperazines substituted with5-membered heterocycles |
| 01/07/2010 | US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 01/07/2010 | US20100004246 Novel triazinedione derivatives as gabab receptor modulators |
| 01/07/2010 | US20100004221 Thiazepine derivative |
| 01/07/2010 | US20100004220 Indenoisoquinolinone Analogs and Methods of Use Thereof |
| 01/07/2010 | US20100004219 Modulators of glucocorticoid receptor, ap-1, and/or nf-kappabeta activity and use thereof |
| 01/07/2010 | US20100004217 Topical steroidal formulations |
| 01/07/2010 | US20100004216 Medicinal lipolysis of accumulation of fat |
| 01/07/2010 | US20100004188 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides |
| 01/07/2010 | US20100004184 Anti-hypercholesterolemic compounds |
| 01/07/2010 | US20100004172 Compositions for mucosal and oral administration comprising hcg fragments |
| 01/07/2010 | US20100004167 Csf3r polypeptides and uses thereof |
| 01/07/2010 | US20100004166 Endothelin and Endothelin Receptor Agonists in the Treatment of Metabolic Diseases |
| 01/07/2010 | US20100004159 Substituted imidazolone derivatives, preparations and uses |
| 01/07/2010 | US20100004158 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 01/07/2010 | US20100003289 Controlled Release Complex Formulation For Oral Administration of Medicine For Diabetes and Method For The Preparation Thereof |
| 01/07/2010 | CA2729897A1 Rna antagonist compounds for the inhibition of expression of mitochondrial glycerol-3-phosphate acyltransferase 1 (mtgpat1) |
| 01/07/2010 | CA2729764A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | CA2729690A1 Novel pyrrolo [2,3-a] carbazoles and use thereof as pim kinase inhibitors |
| 01/07/2010 | CA2729412A1 Novel spirochromanone carboxylic acids |
| 01/07/2010 | CA2729408A1 Triazole derivative or salt thereof |
| 01/07/2010 | CA2729343A1 Topical steroidal formulations |
| 01/07/2010 | CA2729313A1 Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists |
| 01/07/2010 | CA2729286A1 Nutritional compositions containing punicalagins |
| 01/06/2010 | EP2141168A1 Heteroaryl derivatives |
| 01/06/2010 | EP2141155A1 Prophylactic and/or therapeutic agent for hyperlipemia |
| 01/06/2010 | EP2141154A1 Oxazolidinone derivative having inhibitory activity on 11 -hydroxysteroid dehydrogenase type i |
| 01/06/2010 | EP2141150A1 Bicyclic compound and pharmaceutical use thereof |
| 01/06/2010 | EP2141147A1 Ornithine derivative |
| 01/06/2010 | EP2141146A1 Calcilytic compounds |
| 01/06/2010 | EP2140884A1 A vaccine preventing and/or treating autoimmune diseases |
| 01/06/2010 | EP2140268A1 Method for controlling glucose uptake and insulin sensitivity |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2139862A1 Cosmetic preparations designed to reduce unsightly cellulite |
| 01/06/2010 | EP2139843A1 Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators |
| 01/06/2010 | EP2139524A1 Multivalent heterobifunctional polymers and methods of their use |
| 01/06/2010 | EP2139508A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/06/2010 | EP2139494A1 Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate |
| 01/06/2010 | EP2139485A2 Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring |
| 01/06/2010 | EP2139480A1 Ranolazine for enhancing insulin secretion |
| 01/06/2010 | EP2139465A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 01/06/2010 | EP2139332A1 Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators |
| 01/06/2010 | EP1735278B1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/06/2010 | EP1697401B1 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 01/06/2010 | EP1575938B1 Compounds having selective inhibiting effect at gsk3 |
| 01/06/2010 | EP1513831B1 Novel compounds, their use and preparation |
| 01/06/2010 | EP1427713B1 Benzothiazepine derivatives for the treatment of hyperlipidemia |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | EP0963197B1 Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/06/2010 | CN201375684Y Simvastatin and nicotinic-acid double release capsule |
| 01/06/2010 | CN101622032A Method of preventing or treating metabolic syndrome |
| 01/06/2010 | CN100577660C N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists used for the treatment of diabetes |
| 01/06/2010 | CN100577651C Lactam compound and medicinal use thereof |
| 01/06/2010 | CN100577633C CaSR antagonist |
| 01/06/2010 | CN100577201C Treatment of diabetes |
| 01/06/2010 | CN100577189C Fat-benefiting health care composition capsule and its preparing method |
| 01/06/2010 | CN100577183C Lipoic acid health food and application thereof |
| 01/06/2010 | CN100577175C Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| 01/06/2010 | CN100577163C Compounds effecting glucokinase |
| 01/06/2010 | CN100577159C Myricetin dispersion tablets for treating cardio-cerebral blood vessel diseases and preparation method thereof |
| 01/06/2010 | CN100577158C Method for preparing Tengchasu dispersibletablet and its use |
| 01/06/2010 | CN100577157C Dispersant tablet containing hypolipidemic component and preparation method thereof |
| 01/06/2010 | CN100577036C Use of pullulan as a slowly digested carbohydrate |
| 01/05/2010 | US7642378 Lipid lowering biphenylcarboxamides |
| 01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
| 01/05/2010 | US7642286 Stable pharmaceutical compositions containing pravastatin |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642262 Arylipiperdinopropanol and arylipiperazinopropanol derivatives and pharmaceuticals containing the same |
| 01/05/2010 | US7642261 Treating bipolar disorder, mania, dementia, sexual dysfunction, eating disorders, fibromyalgia |
| 01/05/2010 | US7641924 Proteins, lipids and carbohydrates including glucose and fructose heterodisaccharides; slow hydrolysis |
| 01/05/2010 | US7641922 Preparation and application of transhintotalphenolic acid |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641823 Synthesis of small particles |
| 01/05/2010 | CA2465723C Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2349475C Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 12/31/2009 | US20090326233 4-phenylpiperidine compounds |
| 12/31/2009 | US20090326218 Azepinoindole and Pyridoindole Derivatives as Pharmaceutical Agents |
| 12/31/2009 | US20090326215 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 12/31/2009 | US20090326066 Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of nep inhibitors |
| 12/31/2009 | US20090326058 CaSR Antagonist |
| 12/31/2009 | US20090326048 Method for Enhancing Pancreatic Beta Cell Proliferation, Increasing Serum Insulin Concentration, Decreasing Blood Glucose Concentration And Treating And/Or Preventing Diabetes |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090326009 Novel 1-2-Dihydroquinoline Derivative Having Glucocorticoid Receptor Binding Activity |
| 12/31/2009 | US20090326000 Resveratrol formulations and methods of use |
| 12/31/2009 | US20090325983 New purine derivatives |
| 12/31/2009 | US20090325982 Phosphodiesterase 4 inhibitors |
| 12/31/2009 | US20090325981 Compounds and compositions as lxr modulators |
| 12/31/2009 | US20090325980 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 12/31/2009 | US20090325968 Compositions Useful as Inhibitors of Protein Kinases |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325956 Aromatic amine derivative and use thereof |
| 12/31/2009 | US20090325944 Methods and Compositions for Modulating Glycosylation |